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PERSPECTIVES ON LIVER REGENERATION
H. TREMBLEY 1 AND C LIFFORD]. STEER 2
Department of Medicine
University of Minnesota Medical School

jANEEN

Biological regeneration is a topic which has fascinated
scientists for centuries. In the 18th century, scientists observed
the ability of various animals to replace amputated limbs and
entire body segments following bisection. 1 Dramatic examples of
regeneration such as these are mainly restricted to invertebrate
animals. One notable exception is the ability of the urodele
amphibians, such as the newt, to regenerate tail, limbs, jaws and
ocular tissues. The replacement of a limb complete with the
various cell types such as cartilage, muscle and bone is an
example of regeneration defined in the classic sense. The liver has
the remarkable ability to fully replace lost tissue mass and cells
after acute injury. The regrowth of the liver following tissue
removal or other injury is traditionally termed regeneration but is
technically compensatory hyperplasia. One key difference lies in
the fact that while cell number, cell type and organ mass are
faithfully replaced, the original gross morphology is not
duplicated. For example, two-thirds partial hepatectomy in the
mouse or rat entails the removal of the left lateral and median
liver lobes. The regrowth of the remnant liver results in
essentially tripling the mass and cell number of the remaining
lobes.
The liver is an epithelial organ composed of parenchymal
cells, or hepatocytes, and nonparenchymal cell types including
Kupffer, Ito, bile duct epithelial (cholangiocytes) and fenestrated
endothelial cells. The liver performs many essential functions
such as glucose regulation, synthesis of blood proteins, secretion
of bile and drug metabolism. The optimal mass of the liver
required to perform these functions is determined by body size
and the liver is remarkably adaptable to changes in demand. For
example, transplanted livers grow or shrink in size in response to
the body mass and demands of the recipient. Once liver mass falls
below the optimal threshold level due to physical, chemical or
biological injury, the liver responds by initiating growth until the
threshold level is again achieved. Liver growth which is initiated
by a mitogenic stimulus without coincident liver cell loss is
neither a regenerative nor compensatory growth response, but
rather is termed direct hyperplasia and is the subject of another
review.2 This review will address the regenerative growth
response.
AN OVERVIEW OF THE REGENERATIVE PROCESS

Adult hepatocytes are normally quiescent, highly
differentiated cells exhibiting little mitosis (only 1 in 10,000 to
20,000 cells). A variety of injuries can result in liver cell loss and
regrowth. These include chemical injuries such as carbon
tetrachloride administration and viral infection. A well
characterized model for liver regeneration is the 70% partial

hepatectomy (PH), which will be the basis for much of the
information presented in this review.
After resection of the left lateral and median liver lobes, an
ordered sequence of events occurs. The multitude of events which
occur post-PH can be characterized by three major phases (fig 1).
The first phase involves priming the remnant liver cells for
growth in which the remaining hepatocytes and nonparenchymal
cells synchronously exit their resting G 0 state and enter the G 1
phase of the cell cycle. The second phase includes progression
through one or more cell division cycles. The final phase involves
organization of the newly replicated cells and extracellular matrix
for normal liver function .
The priming events of the first phase include immediate
changes in membrane potential, rapid influx of sodium, increased
intracellular pH, calcium release from intracellular stores and an
increase in urokinase receptor and urokinase activity within 5
minutes. Furthermore, cytokine and growth factor signaling occur
within 30 minutes post-PH and are the catalyst for subsequent
events. Latent transcription factors within the liver cells are
activated and, in turn, induce immediate-early genes. In phase
two, delayed-early genes are activated followed by DNA
synthesis and progression through the cell cycle. Two waves of
cell division typically follow PH. The first major wave of cell
proliferation involves primarily hepatocytes while subsequent
proliferation also includes nonparenchymal cells. Peaks in DNA
synthesis for the rat occur predictably around 18-24 hours and 4248 hours post-PH, with the first peak representing a more
dramatic and synchronous period of DNA replication. The time
course of liver regeneration in the mouse is typically delayed by
approximately 12 hours compared to the rat. Mitosis proceeds 6
to 8 hours after DNA synthesis. In young adult rats, as many as
95% of the hepatocytes undergo at least a single cycle of
replication and within 4 days the majority of liver cells has been
replaced. Finally, in phase three, remodeling of the liver cells
occurs. Within 7 to I 0 days the extracellular matrix
microarchitecture and liver mass are restored and the normal
complement of liver specific gene expression is present.
THE POTENTIAL FOR HEPATOCYTE PROLIFERATION

There is abundant evidence that existing hepatocytes are the
source of new hepatocytes in both adult liver regeneration and in
postnatal liver development. Hepatocyte proliferation and the
origin of newly replicated cells can be examined in vivo by at
least two distinct processes. The first is that of liver regeneration
induced by PH. The second occurs in developing animals where,
in rodents, the liver mass increases approximately I 0-fold
between 1 and 4 weeks of age. Taking advantage of this
developmental period of liver growth, cell replication was
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monitored in mice transgenic for the human o: 1 -antitrypsin/~
galactosidase expression construct. Blue transgenic cells which
began as singlets or doublets randomly scattered in neonatal
livers were later present in large clusters in young adult rats. 3
These results indicate that the blue-marked cells arose from
preexisting hepatocytes and did not migrate from a stem cell
compartment.
Hepatocytes have a remarkable capacity for repeated
proliferation and are long-lived cells which, in rodents, remain
viable for more than 2 years. Similar to the experiment described
above, the use of transgenic mice provided useful information on
the clonogenic potential of hepatocytes. First, transgenic mice
expressing the urokinase plasminogen activator (uPA) coding
sequence were constructed. Expression of this gene produced
elevated plasma uPA and fatal hemorrhaging in newborn mice. 4
Interestingly, two lines of uP A transgenic mice were established
from surviving founder mice in which uPA was expressed at low
levels. Within these transgenic lines, half of the offspring died
due to hemorrhage but the remaining offspring appeared normal
and survived. In those mice, a spontaneous genetic rearrangement
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Figur e 1. Sequential events after partial
hepatectomy in the rat can be subdivided into
three major phases. The diagram illustrates the
types of regulatory events involved, including
increased expression of immediate- and
delayed-early genes, active participation of
members of the cyclin family and modulation of
certain apoptosis-associated gene products. Cell
cycle progression for nonparenchymal (NP)
cells is typically delayed approximately 24
hours compared to hepatocytes. The complexity
of the entire process is as profound as the
simplicity of this diagram. Other details are
described in the text.
Abbreviations: cdk, cyclin-dependent kinase;
EGF, epidermal growth fac tor; G6Pase,
glucose-6-phosphatase; HGF, hepatocyte
growth factor; IL-6, interleukin-6; LRF, liver
regeneration factor; MKP, map kinase
phosphatase; NF-KB, nuclear factor-KB ;
PEPC K, phosphoenolpyruvate carboxykinase;
PH, partial hepatectomy; PRL, phosphatase of
regenerating liver; Stat3, signal transducer and
of
transcription-];
TGFu,
act ivator
transforming growth factor alpha; TNFu, tumor
necrosis factor alpha; uPA, urokinase
plasminogen activator.

had occurred which shut down expression from the uP A gene.
The hepatocytes containing the rearrangement displayed a
marked proliferative advantage and repopulated the livers. 5
Second, the toxic, chronically regenerative effect of uPA
expression in these transgenic mice was used to determine
whether adult liver cells rather than neonatal cells could
repopulate an impaired liver. Genetically differentiable donor
hepatocytes were transferred into transgenic uPA mice by splenic
injection and were able to proliferate and replace up to 80% of the
recipient parenchyma.6 Furthermore, these livers retained the
ability to regenerate following PH. Finally, rat hepatocytes were
transplanted into immunosuppressed uP A transgenic mice where
most of the recipient mouse liver was replaced by rat
hepatocytes.? Overall, rat liver can regenerate at least 12 times,
and a single hepatocyte has the theoretical clonogenic capacity to
undergo at least 34 divisions and generate 50 rat livers.s These
results have exciting potential for gene therapy applications, as
discussed in a later section.
One of the striking features of liver regeneration is that these
highly differentiated cells simultaneously proliferate and
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continue to perform the functions necessary for viability of the
organism. Moreover, the regrowth of the liver following PH does
not involve a significant stem cell component. There are many
definitions of stem cells in the literature. One definition is that
stem cells are pluripotent and can self renew. Thus, a liver stem
cell should be capable of producing different hepatic cell types as
well as replicating into other stem cells. Data presented to date
strongly suggest the presence in the liver of a bipotent stem cell
called the oval cell. These cells can differentiate in culture into
either hepatocytes, bile ductule cells and possibly other cell
types.9 Taken one step further, the hepatocyte can be viewed as a
unipotential stem cell since this fully, but not terminally,
differentiated cell can respond to regenerative signals and
reproduce itself. Following 60-70% cell loss due to PH, the liver
is still able to carry out the necessary functions for organ viability
without activation of its stem cells. However, if damage to the
liver is severe enough that liver function is compromised and the
hepatocytes cannot proliferate, oval cells are activated and
replicate. This is illustrated in an experimental model of liver
regeneration in which treatment with 2-acetylaminofluorene
(AAF) is followed by PH. The AAF treatment inhibits hepatocyte
mitosis thus provoking an oval cell-mediated regeneration
response post-PH.9
GROWTH FACTOR AND CYTOK.INE SIGNALING

The role of growth stimulatory and, to a lesser extent,
growth inhibitory factors in the liver's regenerative response have
been extensively investigated in the hopes of identifying the key
'start' and 'stop' signals. However, the precise role of various
positive and negative growth factors still remains unclear. A
complete mitogen is a substance which is capable of stimulating
DNA synthesis and mitosis of cultured cells in serum-free media.
Transforming growth factor alpha (TGFa), epidermal growth
factor (EGF) and hepatocyte growth factor (HGF), or scatter
factor, are each complete mitogens for liver cell growth. Hepatic
comitogens alone do not cause proliferation of liver cells in
culture but act to enhance the stimulatory effect of complete
mitogens. These include insulin, glucagon, insulin-like growth
factors, norepinephrine, various hormones, calcium, vitamin D
and certain nutrients. Finally, several liver growth inhibitors have
been identified including the transforming growth factor beta
(TGF~) family and interleukin I 0 (IL-10).
Research into the role of growth factors in liver cell
proliferation has been performed in vitro using primary
hepatocytes due, in part, to the improved ability to manipulate the
cellular environment. Hepatocytes are isolated for primary
culture by collagenase perfusion. The process causes these cells
to leave G0 and enter G 1. Following isolation and plating, several
genes which traditionally mark the early to middle G 1 phase of
the cell cycle are expressed. These genes include c-fos, c-jun, cmyc, and p53. However, when grown in serum-free media, these
primary hepatocytes cannot progress through G 1 into S phase
(DNA synthesis) without the addition of growth factors. Thus,
primary hepatocytes are primed for proliferation and are
responsive to growth factors in contrast to resting or quiescent
hepatocytes in vivo which are not responsive to growth factors .
Loyer and colleagues determined that the mitogen-dependent
restriction point in adult rat hepatocytes occurred in mid to late
G 1, or 42-48 hours after seeding. 10 The addition of either EGF or
TGFa in conjunction with the cofactor pyruvate was sufficient to
allow these cells to progress through DNA synthesis.
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Removal of 30% of the liver creates a situation similar to
collagenase isolation of primary hepatocytes. The cells in the
remnant liver exit G 0 and are primed for DNA synthesis, but
require the addition of growth factor(s) to enter S phase. Fausto
and colleagues infused growth factors into the mesenteric veins of
rats for 24 hours using an osmotic pump placed in the peritoneal
cavity. They found that quiescent hepatocytes exhibited little
response to HGF, EGF, and TGFa; but if the liver cells were first
primed by 30% PH, cell cycle progression occurred. ll

Epidermal growth factor and transforming growth
factor-a
Basal levels of EGF RNA are detectable in rat liver using the
reverse transcription polymerase chain reaction technique. 12 EGF
RNA abundance increases by 10-fold within 15 minutes post-PH
then diminishes below basal levels around 4 hours post-PH .
Fractionation of liver cells prior to RNA isolation revealed that
EGF RNA was expressed by hepatocytes and Ito cells, whereas
the EGF receptor RNA was identified in hepatocytes, endothelial,
Kupffer and Ito cells. Typically, EGF is synthesized as a 140
kilodalton (kDa) transmembrane precursor protein that is
processed and released from the cell surface as a 6 kDa signaling
peptide. However, in regenerating liver, EGF protein accumulates
in rat and mouse hepatocytes as a 60 kDa polypeptide. 12 This
work established that an autocrine mechanism exists for EGF
signaling during liver regeneration.
Both EGF and TGFa bind the EGF receptor. Binding of the
receptor leads to autophosphorylation which exposes a
recognition site for SH2 domain-containing proteins and causes
phosphorylation of cellular substrates which, in tum, affect
transcription. In the rat, the number of EGF receptors increases by
approximately 2-fold in the first 3 hours post-PH then decreases
again until day 4. 13 The majority of EGF in mouse and rat is
produced in the salivary glands. Removal of the salivary glands in
the mouse 2 weeks prior to PH resulted in a 50% decrease in
plasma EGF concentration, abolished the increase in EGF levels
post-PH, and greatly delayed peak DNA synthesis. 14 Injection of
EGF restored the time course of the regenerative response. In the
rat, sialoadenectomy at the time of or 3 hours post-PH decreased
DNA synthesis and mitosis by 50% but did not affect the
expression of the early response genes c-jun, c-fos and c-myc . l5
If salivary gland removal was performed 6 hours or more postPH, no reduction in DNA synthesis was observed. Furthermore,
administration of EGF from 3 to 9 hours post-PH in
sialoadenectomized rats was sufficient to restore normal
regenerative activity. These authors observed that overall,
diminished EGF levels delayed the regeneration response to PH
in the first 24 hours, but liver mass recovery in
sialoadenectomized versus control rats was similar 7 days postPH. Thus, EGF appears to affect early G 1 events in liver
regeneration which occur after the priming phase from 0 to 3
hours post-PH . Jones and colleagues reported a more severe
effect of salivary gland removal 24 hours pre-PH in rats. 16 They
reported that DNA synthesis was inhibited by 90% 24 hours after
33% PH . Thus, it is apparent that EGF signaling during liver
regeneration occurs through both autocrine and endocrine
mechanisms.
TGFa mRNA levels increase 4 hours following PH and
remain elevated for at least 48 hours. TGFa peptide levels
increased 2-fold between 24 and 48 hours via an autocrine loop
mechanism . 11 Hepatocytes produce TGFa and bind the growth
factor through the EGF receptor in the plasma membrane.
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Transgenic mice overexpressing TGFa demonstrate an increased
rate of hepatocyte replication leading to increased liver size. This
is compensated for after 3 to 5 months of life by increased cellular
turnover. 11 Furthermore, by 15 months of TGFa overexpression,
85% of these mice exhibit hepatic tumors. In contrast, TGFa
knockout mice develop normally except for abnormal hair
growth. 17

Hepatocyte growth factor
HGF is produced by mesenchymal cells which, in the liver,
are represented by Ito, Kupffer and endothelial cells. Blood levels
of HGF increase 20-fold by 1 hour post-PH . 8 However,
proteolytic processing of the inactive single-chain form of HGF
to the active form may occur as early as 1 minute post-PH. Active
uPA is responsible for this cleavage post-PH and this protein is
detected I minute post-PH. IS
The importance of this growth factor is highlighted from
HGF knockout mice which die during embryonic development
between days 13 and 16. In these embryos, the liver is reduced in
size, there is extensive loss of hepatocytes and placental
development is impaired. l9, 20 Homozygous deletion of the HGF
receptor, c-Met, also results in embryonic lethality. 21 Overexpression of HGF in transgenic mice produced a phenotype in
which liver regrowth following PH occurred 2 to 3 times faster
than wild type. The resulting liver was larger than normal and
contained smaller hepatocytes with diploid DNA content. 22 ,23
Moreover, the proliferative stimulus of prolonged HGF
expression caused formation of hepatocellular adenomas and
carcinomas in most transgenic mice beyond 1.5 years of age.23
Finally, overexpression of a truncated c-Met receptor containing
the regulatory and catalytic cytoplasmic domains caused a block
to apoptosis and permited immortalization of these transgenic
hepatocytes. 24 These results indicate that HGF may play an
essential role in liver morphogenesis and that deregulated HGF
signaling is oncogenic for hepatocytes.

Tumor necrosis factor-a and interleukin-6
The cytokines tumor necrosis factor (TNF)a, IL-6, and ILl 0 are also expressed by non parenchymal cells of the liver and
expression for these factors increases within 3 hours post-PH .25
Recent data strongly support a signal pathway(s) in which TNFa,
IL-6 and IL-l 0 interact in regulating each other. EGF and IL-6
activate the transcription factor signal transducer and activator of
transcription-3 (Stat3) and TNFa induces nuclear factor (NF)-KB
transcription factor activation .26-Z8 Mice homozygous for an IL6 gene deletion are developmentally normal but exhibit a
dramatic decrease in the number of S phase hepatocytes during
liver regeneration. 29 In conjunction with decreased response in
DNA synthesis, these mice demonstrate no Stat3 activation and
decreased c-fos, junB, c-myc and cyclin Dl expression. In
contrast to the effect of IL-6 depletion on hepatocyte proliferation
during liver regeneration, nonparenchymal cells exhibited DNA
synthesis and gene expression patterns similar to wild type mice.
One further effect of IL-6 deficiency was the development of
necrotic areas in the liver. Liver regeneration does occur
eventually in these IL-6 negative mice. Injection of IL-6 prior to
PH restores Stat3 activation and nearly normal hepatocyte
proliferation. lL-6 knockout mice exhibited increased death
following PH. Specifically, 40% of knockout mice died post-PH
versus 10% mortality in wild-type and 8% death in knockout mice
which received an IL-6 injection pre-PH.
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Treatment of rats with antibodies to TNFa prior to surgery
inhibited liver regeneration after PH. The effects of antibody
injection included decreased DNA synthesis 24 hours post-PH,
significantly decreased serum IL-6 and diminished induction of
activator protein-! (AP-I) transcription factor activity.30 In
addition, mice deficient in type I TNFa receptor (TNFR-1)
displayed severely impaired DNA synthesis, no detectable
activation of Stat3 or NF-KB , decreased AP-I activity and lower
IL-6 levels. 31 Furthermore, 50% of these animals died between 3
and 5 days post-PH with the surviving mice demonstrating
slower liver regeneration. The loss of TNFa receptors can be
compensated for by injection of IL-6 30 minutes before PH . This
restored DNA synthesis and the Stat3 pathway, but not NF-KB
DNA binding. Normally, TNFa levels are downregulated
posttranscriptionally by IL-l 0 and TGFI3!. Treatment of rats with
gadolineum chloride (GdCl) depletes the liver of active Kupffer
cells and increases TNFa and TNFa-inducible cytokines such as
IL-6. After PH in GdCl treated rats, induction of IL-l 0 was
greatly decreased, TNFa was transiently overexpressed and the
regenerative response was greater than normal. 25 Since TGFI3l
expression is not significantly affected by GdCl treatment prior to
PH, TGFI3! is thought to affect TNFa downregulation in these
animals.
The results of TNFa and IL-6 on liver regeneration suggest
a signaling pathway in which PH induces expression of TNFa
followed by activation of NF-KB which induces IL-6. IL-6 causes
activation of Stat3. Activation of Stat3 and NF-KB together
initiates immediate-early gene expression. Expression of both lL10 and TGFI3! acts to prevent TNFa overexpression.
Furthermore, increased stress-activated protein kinase activity
following PH might play a positive role in proliferative signaling
during regeneration, possibly by stimulating IL-6 production32

Growth inhibitors
Expression of the growth inhibiting cytokines TGFI3l , 2 and
3 is increased following PH.33 TGFI32 and TGF(33 expression
peak early post-PH, whereas TGFI3l expression peaks around 48
hours. TGFI3 isoforms are transcribed by both nonparenchymal
and parenchymal cells following PH, however, hepatocytes
release latent TGFI3 whereas nonparenchymal cells release active
TGFI3. 33 TGFI3I is the best characterized of the three TGFI3
isoforms and receptors for this molecule are present on virtually
all cells. Transgenic mice in which a mature form of porcine
TFGI3l , under control of the mouse albumin promoter was
expressed, exhibited increased hepatocyte mitotic and apoptotic
activity and hepatic fibrosis .34 Furthermore, high plasma
expression levels of the transgene negatively affected other
organs, most notably the kidneys. Finally, inhibin-beta C is a
recently identified TGFI3 family member whose gene expression
is downregulated by at least 8-fold following PH in the mouse. 35
THE IMMEDIATE-EARLY GROWTH RESPONSE

Similar to other mitogenic conditions, the regenerating liver
uses multiple signal transduction pathways. Most signaling
pathways begin with ligand binding to specific receptors. The
event transduces a signal by mechanisms such as receptor autophosphorylation and subsequent binding of protein complexes,
kinase activity of the receptor, or coupling of the receptor to other
signaling systems such as G-proteins. For example, binding of
receptor tyrosine kinases by the growth factors EGF, TFGa and
HGF following PH are most likely key events initiating early
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growth response pathways. Much of the information about signal
transduction pathways has been defined in other systems and in
isolated hepatocytes and will not be reviewed here. The early
growth response is dependent upon immediate-early gene
expression, has been extensively investigated in regenerating
liver and provides the basis for the following discussion.
The primary growth response after PH consists of the
transcriptional activation of immediate-early genes, which is
initi ally accomplished through activation of latent transcription
factors. By definition, immediate-early genes do not require
protein synthesis for their activation. Preexisting factors within
liver cells function to activate genes normally quiescent in these
mature, differentiated cells. It is generally accepted that increased
circulation of growth factors like those described above triggers
this response. Two key transcriptional activators are Stat3 and
partial hepatectomy factor (PHF)/NF-KB , a liver specific form of
NF-KB .36 Both of these DNA-binding factors are activated by
phosphorylation events. Stat3 activation and nuclear translocation
occur by phosphorylation of a tyrosine residue, and
phosphorylation of the inhibitor protein IkBa or RUIF-1 results
in release of PHF/NF-KB . PHF/NF-KB DNA-binding activity
peaks at 30 to 60 minutes post-PH , whereas Stat3 activity is
induced by 30 minutes but peaks at 2 to 3 hours post-PH.
Many transcription factors are induced as immediate-early
genes, resulting in a transcriptional cascade during the G 1 phase
of the initial liver regeneration cell cycle. Leucine zipper
transcription factors which dimerize to form AP-I type
transcriptional complexes are important participants in this
induction . High levels of AP-I DNA-binding complexes
containing the proteins c-Jun, JunB , c-Fos, and the liver specific
partner protein liver regeneration factor-! (LRF-1) are detected
for several hours after the G0 to G 1 transition.36
Two other immediate-early genes involved in proliferative
signaling include EGF and c-myc. The functions of EGF in liver
regeneration were discussed above. The transcriptional activator
protein c-Myc is a protooncogene which plays a role in both cell
proliferation and cell death. The roles of two immediate-early
genes, map kinase phosphatase (MKP)- 1 and phosphatase of
regenerating liver (PRL)-1, which encode protein tyrosine
phosphatases, have yet to be delineated.36 The discovery of novel
phosphatase gene activation during liver regeneration is
intriguing because of the role played by the cdc25 phosphatase
family in activating cyclin/cyclin dependent kinase (cdk)
complexes during cell proliferation. The parallel induction of
most immediate-early genes in hepatocytes as well as
n.onparenchymal cells provides evidence that the exit from G0 is
stmultaneous for all cells in the remnant liver.37 Moreover,
because DNA synthesis in nonparenchymal cells occurs in the
second wave of cell proliferation, these data suggest a prolonged
G 1 phase in nonparenchymal cells. Interestingly, activation of
NF-KB and AP-1 and expression of TNFa are specific to the
compensatory hyperplastic response since these effects are not
observed in direct hyperplasia induced by nafenopin or
cyproterone acetate.38
Changes in gene activity post-PH also act to maintain the
liver's functions. For example, several immediate-early genes
encode proteins important for glucose regulation and metabolism,
thus compensating for the loss in liver mass. These genes include
glucose-6-phosphatase, insulin-like growth factor binding
protein-!, and phosphoenolpyruvate carboxykinase.36 Albumin is
also expressed as an immediate-early gene. Thus, the combined
upregulation of immediate-early transcription factor and liver
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function genes allows the remnant liver to both grow and perform
its myriad differentiated functions.
PROGRESSION THROUGH LIVER REGENERATION

Following the transcriptionally regulated immediate-early
gene response occurring from 0 to 3 hours post-PH, gene
expression patterns and regulation become more complex. Work
performed in Taub' s laboratory demonstrated that genes are
induced in three expression patterns following PH.37 The patterns
include growth regulated expression beginning at surgery through
60-72 hours post-PH , cell cycle related expression, and liverspecific gene expression after the growth phase from 60 hours
post-PH and beyond . Work in the Steer laboratory has
investigated mechanisms for gene regulation from all three
categories. One of the main conclusions from this work is that
genes induced beyond the immediate-early phase of liver
regeneration are predominantly regulated at the posttranscriptional level by several different and potentially additive
mechanisms. The following discussion will cover specific
examples of gene regulation post-PH for genes involved in
various aspects of cell proliferation and hepatocyte function.
An interesting example of alternate gene regulation
following PH involves the genes for ornithine decarboxylase
(ODC) and connexin 32 (Cx32). ODC is an RNA helicase
belonging to the DEAD box family and is the rate limiting
enzyme for polyamine biosynthesis required for maximal DNA
synthetic activity.39 ODC transcript levels increased by 3 hours
post-PH and continued to increase steadily until they reached
peak expression of 37-fold over nonregenerating levels at 24
hours. ODC transcript expression then steadily declined until
baseline levels were again achieved by 96 hours.40 ODC
transcription rate did not change post-PH; however, the in vivo
chemical half-life increased from 2.5 hours in nonregenerating
liver to greater than 12 hours at 24 hours post-PH. Furthermore,
at times of increased ODC mRNA stability and expression, the
gene exhibited demethylation at HinPI I restriction sites and the
transcript was located on heavier polysomes suggesting increased
translation.40 ·41 Moreover, the rate of poly(A) tail removal for
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Regenerating Uver
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No
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Figure 2. Inverse modulation of ODC and Cx32 gene expression in the
regenerating liver after 70% partial hepatectomy. "No change" in
transcription rate is relative to that in the quiescent liver. In addition to
ODC, increases in mRNA half-lives for p53, c-myc and H-ras were also
associated with decreased genomic methylation suggesting a potential
role for DNA methylation in posttranscriptional gene regulation. See
text for details. ODC, ornithine decarboxylase; Cx32, connexin 32;
N.D., not determined .
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ODC transcripts was greatly increased in nonregenerating liver
when the mRNA half-life was shortest compared to a time postPH when half-life was increased.
Cx32 transcripts from the p1 gap junction gene represent an
example of complimentary regulation to that of ODC. Gap
junction proteins form intercellular channels which allow cell-tocell communication. Cx32 transcripts are abundant in
nonregenerating liver and cycle in their pattern of expression
post-PH showing very low levels at 12 and 48 hours but abundant
expression at intervening times.42 This pattern is consistent with
those for other gap junction proteins during liver regeneration.
Fladmark and colleagues proposed that the advantage to
downregulating gap junctions during liver regeneration-induced
cell cycling may be in maintaining separate pools of metabolites
and signaling molecules between hepatocytes that are replicating
and those maintaining liver-specific functions. 43 No change in
Cx32 gene transcription rate was seen during liver regeneration
but the mRNA half-life decreased from 10.9 to 3.8 hours
concordant with decreased transcript abundance at 12 hours postPH.41 Furthermore, Cx32 transcripts were associated with
heavier polysome fractions in nonregenerating liver suggesting
greater mRNA stability. In contrast, the rate of poly(A) tail
shortening increased at 12 hours post-PH consistent with
decreased mRNA stability. Cx32 protein levels paralleled
transcript levels but was slightly delayed. 42 These data,
summarized in figure 2, illustrate that many posttranscriptional
mechanisms of gene regulation are used during liver regeneration
to affect the dramatic fluctuations observed in gene expression.
Thus, the liver has many levels of gene regulation available for
manipulation.

Cyclins and cyclin-dependent kinases
Several laboratories have investigated the cell cycle
regulatory family of cyclins and cdks during liver regeneration.
Cyclins form complexes with members of another family of
genes, the cdks. The cyclin subunit plays a regulatory activating
role and the serine/threonine protein kinase catalyzes final
phosphorylation. It is apparent that most, if not all, transitions and
checkpoints in the eukaryotic cell cycle involve cyclinlcdk
activity. Cyclins and their partner cdks form complexes which are
active at specific times during the cell cycle. Targets for
cyclinlcdk kinase activity include retinoblastoma tumor
suppressor protein, histone H 1, E2F-1 and RNA polymerase 11. 44
At the transcript level, most of the cyclins and cdks exhibit
cell cycle-dependent expression which peak at cell cycle time
points in which they are known to be active.45 -4 7 However, the
cycling pattern of transcript expression exhibited by these genes
is not due to changes in transcription rate as detectable by nuclear
run-on assays; and changes in mRNA stability only partially
account for the transcript flu ctuations observed.45 ·48
Furthermore, cyclin steady-state protein levels do not consistently
correlate with mRNA expression patterns.46 For example, in
contrast to transcript expression, cyclin B 1 protein is readily
detectable in nonregenerating liver and total liver expression level
does not change appreciably during regeneration.47 However, the
steady-state expression pattern for cdk 1 does occur in a cell cyclerelated manner and cyclin B/cdkl kinase activity is detected at the
appropriate mitotic phase during the first wave of
regeneration.46.47 Cyclin A also is detected in resting liver and a
unique tyrosine-phosphorylated form was detected during the G 2
phase of the first wave of cell proliferation following PH. 49
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p53
The p53 tumor suppressor gene product is a critical
component in cellular pathways for DNA damage-induced G 1
and G2 arrest as well as for apoptosis. p53 is a transcription factor
which binds to and activates, in a signal sp-ecific manner, various
response genes inducing the cdk inhibitor p21 and the apoptotis
gene oax .so Mice in which the p53 gene has been knocked out
are viable but exhibit pronounced tumor formation. Steady-state
mRNA and protein levels are loosely coupled for p53 during liver
regeneration. The p53 gene is induced in a delayed-early manner
and transcript expression peaks at 6 hours post-PH exhibiting a
35-fold increase over nonregenerating liver. 40 p53 transcript
levels then exhibit two further peaks irrexpression (15- to 20-fold
over baseline) 24 and 42 hours post-PH. Protein levels for p53
peak 5-fold over baseline 6 to 12 hours post-PH and 40-fold over
baseline 30 hours post-PH in the rat.5 1 Thus, maximal p53
protein levels in regenerating liver correlate with G 1 and mitosis
in the first wave of cell division.
p53 plays a role in sensitizing hepatocytes to both growth
and death signals. Quiescent hepatocytes from p53 null mice are
phenotypically normal. However, once these cells are released
from G0 by isolation for culture, a greater proportion of p53 null
cells enter DNA synthesis than wild-type hepatocytes.52
Induction of liver regeneration by carbon tetrachloride in p53
knockout mice also resulted in greater DNA synthetic activity.
Furthermore, isolated p53 null cells are less responsive than wildtype cells to the addition of the mitogens EGF, insulin and fetal
bovine serum as well as to mitosuppressive agents such as TGFP.
In contrast, the livers of p53 null mice were more responsive in
vivo to a nongenotoxic mitogen.
p53 plays an integral role in G 1 and G2 checkpoint arrest in
gamma-irradiated hepatocytes. Irradiation of mice 48 hours after
carbon tetrachloride-induced liver regeneration (late G 1) resulted
in reduced hepatocyte G 1/S arrest in p53 null versus wild-type
mice.52 This was followed by a striking rise in the mitotic index
24 hours after irradiation, indicating no significant G2 arrest in
response to DNA damage. However, many of the mitotic figures
were abnormal, suggesting that the mitotic peak resulted from
damaged hepatocytes proceeding to and arresting in mitosis. p53
appears to be important in the regulation of proliferating, but not
quiescent, hepatocytes.

p21
p21 is a member of the cdk inhibitor (CKI) family of genes.
The CKI proteins can inhibit cyclinlcdk kinase activity by
binding to either the complex or the cdk alone. As mentioned
previously, the p21 gene contains p53 binding sites and the p21
protein product is hypothesized to be a key downstream mediator
of p53 regulatory pathways. In correspondence with this notion,
p21 is induced by many of the same cellular signals which induce
p53. Alternately , p21 also is induced during cellul ar
senescence 44 . Albrecht and colleagues observed that p21
transcripts were barely detectable in mouse and rat liver pre-PH
but the abundance increased by 1 hour post-PH.53 Transcript
levels decreased at the onset of DNA synthesis in both rodents
then increased again. Dietary protein deprivation also resulted in
increased p21 mRNA expression. Moreover, the same pattern of
p21 induction was exhibited in both p53 null and wild-type mice
post-PH. However, following protein deprivation, the increase in
p21 transcript expression after PH was p53-dependent. p21
expression was induced in cycloheximide pre-treated mice
subjected to PH, defining p21 as an immediate-early growth
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response gene. p21 transcript expression post-PH is
predominantly regulated at the posttranscriptional level, which
suggests why the p21 gene response in PH-stimulated
regenerating liver is independent of p53.53
A liver specific minigene construct was used to create
transgenic mice overexpressing p21 in the liver.5 4 Endogenous
p21 was undetectable in the liver by two methods whereas the
transgenic livers expressed readily detectable p21 in the
hepatocytes. Transgenic mice exhibited decreased liver mass by
49 to 62%, overall stunted growth and a shorter lifespan.
Furthermore, there were fewer hepatocytes, more nonparenchymal cells than normally observed and an abundance of oval
cells. This is consistent with the notion, stated earlier, that if
hepatocytes are impaired from proliferating, oval cell replication
will increase. The majority of cyclin D1 and cdk4 proteins in
hepatocytes were found complexed with p21 which indicates that
phosphotransfer activity is inhibited for this kinase. No detectable
increase in apoptosis was observed. Following PH in the p21
overexpressing mice, DNA synthesis was less than 15% of
normal values and occurred mainly in oval cells. Furthermore, no
mitoses were observed indicating a possible G2 block as well.
Thus, p21 overexpression results in a dominant negative effect in
the normal regenerative response to PH. Additionally, mice
lacking p21 develop normally but exhibit defective G 1 arrest in
response to DNA damage or nucleotide pool perturbation.55
APOPTOSIS IN THE LIVER

Similar to other cells in culture, hepatocytes demonstrate
signal-specific responses to apoptotic stimuli. Several gene
products have been identified which have an antiapoptotic effect.
These proteins include the retinoblastoma (Rb) tumor supressor
gene product and the apoptosis-associated gene products, Bcl-2
and Bcl-XL. Rb is a key regulatory protein for the progression
from G 1 to S phase of the cell cycle and also plays a role in
development. 56 The functions of Rb are controlled through
fluctuations in the protein's phosphorylation status.
Hypophosphorylation inhibits, whereas hyperphosphorylation
allows, entrance into S-phase and cell cycle progression. Loss of
functional Rb in the cell results in deregulation of transcriptional
activity and either tumorigenesis or apoptosis. Mice lacking the
Rb gene die during embryogenesis and demonstrate increased cell
division and apoptotic cell death in the hematopoietic and
nervous systems, liver, and skeletal muscle precursor cells.
Rb appears to play a protective role against apoptosis in
hepatocytes. Rb protein expression peaks at 12, 30, and 72 hours
post-PH in the rat, with expression at 30 hours representing a
greater than 100-fold increase over nonregenerating Rb
abundance.5 1 Rb transcript expression is uncoupled from that of
the protein.57 TGFPl treatment inhibited Rb gene expression and
protein phosphorylation in culture, while Rb protein expression
was inhibited in regenerating liver.5I ,58 In vitro, this TGFP1
induced reduction in Rb protein abundance and phosphorylation
resulted in apoptosis in both primary rat hepatocytes and in HuH7 human hepatoma cells.58 Furthermore, depletion of Rb protein
expression by antisense oligonucleotide also resulted in
hepatocyte death. Overexpression of Rb inhibited the apoptosis of
hepatic cells induced by TGFpl, Rb antisense and REC2 (DNA
recombinase). 51·58 ·59
The bcl-2 gene family members bcl-2 and bel- XL also act to
protect cells from apoptosis. In fact, overexpression of either of
these genes can block apoptosis from numerous stimuli.60 Bcl-2
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and bcl-XL gene expression occurs early during regeneration with
maximal expression 6 hours following PH.61 Bcl-2 transcripts are
expressed by nonparenchymal cells and exhibit less than 2-fold
induction whereas bcl-XL transcripts are expressed by
hepatocytes and exhibit greater than 20-fold induction. Bcl-2 and
Bcl-XL protein levels do not fluctuate significantly during
regeneration. Coupled bcl-XL transcript and protein expression
occur in a delayed-early response pattern following PH in the
mouse. 62 Most likely, the functions performed by Bcl-2 in other
cell types are fulfilled by Bcl-XL in hepatocytes. HGF is reported
to suppress epithelial cell apoptosis, and interestingly, BAG-1 (an
anti-apoptotic protein) associates with the c-Met receptor for
HGF, thus linking HGF antiapoptotic effects with the survival
branch of the bcl-2 family.63
Other members of the bcl-2 family are proapoptotic in
fu nction. These gene products include Bax, Bad, and Bak. Bax
homodimers promote cell death, while bax heterodimers formed
with Bcl-2 or Bcl-XL do not. Bad and Bak can also bind to Bcl-2
and Bcl-XL, thus promoting the formation of Bax homodimers
and cell death. Bax transcript and protein abundance increase
following PH in the rat in a stepwise fashion .61 The Bax protein
is most abundant in regenerating liver during the period when
proliferation has predominantly ceased and apoptosis-mediated
reorganization of the liver is occurring. Similarly, Bax protein
abundance increases follow ing withdrawal of the drug clofibrate,
an inducer of direct hyperplasia, and is associated with the
increased apoptosis of extraneous hepatocytes.6 1
p53 is a key cellular status sensor which can halt the cell
proliferation machinery in order to effect repairs, but can also
induce apoptosis. Cultured p53 null hepatocytes are able to
survive and proliferate under conditions in which wild-type cells
cease to proliferate and undergo apoptosis. 52 However, these
cells were competent to enter into p53-independent apoptosis
following ultraviolet irradiation. Liver cells can also undergo Fas
ligand/ receptor mediated cell death. Hep 3B human hepatoma
cells, which lack p53, can still undergo apoptosis in response to
apoptotic stimuli .58,S9
R EMODELING OF REGENERATED LIVER AND
EXTRACELLULAR MATRIX

Most studies on liver regeneration focus on proliferation.
However, restoration of liver mass and function also requires
regulation of apoptosis and extracellular matrix (ECM) to effect
the remodeling of parenchymal and nonparenchymal cells into
functional units. Remodeling occurs during development, tissue
repair and regeneration. It requires coordination of matrix
deposition, matrix degradation, cell proliferation and apoptosis.
The hepatocyte is the only epithelial cell in the body not separated
from the vascular space by two continuous basement membranes,
which may allow rapid exchange of components between the
plasma and hepatocytes.64 Actually, hepatic failure due to
cirrhosis results, in great part, from formation of basement
membrane between hepatocytes and the vascular space.
The processes of cell division and subsequent hepatic
remodeling require using preexisting ECM . It is intuitive that
some degradation would take place to facilitate movement.
Activation of uPA occurs within 5 minutes post-PH and this, in
tum, is proposed to initiate a proteolytic cascade resulting in
hepatic matrix degradation and release of active HGF.8 Four days
post-PH, mitotic activity has ceased and hepatocytes exist as
clusters of 10 to 14 cells which lack sinusoids and ECM. 64
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Furthermore, by this point the cell/ECM ratio has greatly
increased. At this time, laminin-positive Ito cells become
detectable and appear to extend processes to invade the
hepatocyte clusters. Fenestrated endothelial cells then penetrate
the clusters and separate the hepatocytes into cell plates, thus
restoring normal hepatic vascular structure. Once this is
accomplished, laminin production ceases. Along with hepatic
plates, the biliary tree must also regenerate in the hepatectomized
liver. Intrahepatic bile duct epithelial cells, or cholangiocytes, line
the intrahepatic biliary tree and function to modify bile. In these
cells, DNA synthesis increased by I day, peaked on day 3 and
returned to control values by 28 days post-PH.65 By I 0 days postPH, the normal distribution of ECM and regrowth of the biliary
tree are complete.
UNANSWERED QUESTIONS AND PERSPECTIVES

There are several key questions which remain unanswered
about liver regeneration. First, what are the critical signals
occurring within minutes of surgery which catalyze the entire
regenerative process? It is unlikely that a single master signal
exists and we now know that even a change in membrane
potential is not a critical event. 66 Following PH, blood flow to the
remnant liver increases 3-fold and is probably responsible for
delivering necessary signaling agents for regeneration. In this
regard, studies performed almost half a century ago revealed that
when two rats are joined parabiotically, PH of one rat causes
proliferation in the intact liver of the other. Furthermore,
regeneration proceeds in a periportal to pericentral pattern in the
direction of portal blood flow within the remnant lobes. Second,
how do liver cells maintain their differentiated functions and yet
exit quiescence to begin proliferating? Third, how does the liver
sense when the optimal mass has been achieved and stop
hepatocyte proliferation? Many genes, such as protooncogenes
and tumor suppressor genes, appear to be involved in multiple
cellular processes, including cell proliferation, development and
apoptosis. While this seems antithetical, it also reflects an
economy of function. A change in the intricate balance between
signals for proliferation and apoptosis can be swiftly acted upon
by key proteins capable of functioning in either pathway.
The ultimate goal of regeneration research is to develop
therapeutics directed to replacing damaged tissues in vivo. In
most vertebrates, the capacity for regeneration is limited to a few
tissues, such as bone, skeletal muscle and, of course, liver. For
bone and muscle, regeneration in some ways recapitulates
embryonic differentiation from stem cells. In contrast, it is widely
accepted that the liver is able to regenerate without activation of
stem cells. But, we also know that hepatocytes can undergo
partial dedifferentiation, allowing them to reenter the cell cycle
while maintaining critical differentiated functions. The liver is not
a salamander or a newt, but it certainly exhibits some remarkable
regenerative properties. The approach of regenerative biology is
to identify the cellular and molecular differences that distinguish
tissue embryogenesis from wound repair and then to recreate an
embryonic regenerative environment in an injured tissue. In fact,
why do tissues scar rather than regenerate? They may even
contain cells competent to undergo replication but lack
stimulatory signals to effect regeneration. On the other hand, they
may be receptive to signals that suppress regeneration and
promote scarring. It seems that most tissues appear to lack stem
cells required for regeneration. However, is it conceivable that
they simply lie dormant with all the machinery necessary for
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regeneration-waiting for just the right combination of stimuli?
Perhaps we should take a closer look at livers and urodeles and
learn from them how to induce regeneration by dedifferentiation.
In the future, we may ultimately develop the technology to
regenerate vital organs. The fun and excitement will be in getting
there!
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